Using whole genome bisulfite sequencing to identify novel therapeutic targets in DIPG and ATRT

CBTTC has the largest collection of these specimens in the world to our knowledge. Access to CBTTC specimens and data will allow us to propel target discovery and vailidation in these two diseases.